CPT code 86806: Lymphocytotoxicity assay, visual, without titration2026 Medicare lab fee · Clinical Laboratory Fee Schedule

A visual lymphocytotoxicity crossmatch assesses recipient serum against donor lymphocytes during compatibility evaluation, without antibody titration.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $47.59 for 86806 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$47.59

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 86806 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 86806 covers

This test is a visual lymphocytotoxicity crossmatch performed without antibody titration. In histocompatibility testing, recipient serum is assessed against donor lymphocytes for cytotoxic reactivity. It is used in donor-recipient compatibility evaluation, including transplant workups, and is performed by histocompatibility laboratories. Unlike cytotoxic antibody screening, this service is a visual crossmatch against donor cells.

Report 86806 for the visual crossmatch service. Medicare pays it through the Clinical Laboratory Fee Schedule (CLFS), with one national amount across states and localities and no geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $47.59, unchanged since 2020. The test is excluded from the physician fee schedule by statute.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 86806

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 86806. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 86806 with status X (excluded by statute), so the test itself is paid only from the CLFS.

86806 on the lab fee schedule since 2020

86806 · CLFS 2026 Q4 (current)

$47.59

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

86806 compared with similar tests

86805Lymphocytotoxicity assayVisual crossmatch with titration$189.51
Both codes identify lymphocytotoxicity assays; 86806 specifically describes the visual crossmatch performed without titration.
86807Transplant antibody screenStandard cytotoxicity method$78.65
86807 is cytotoxic antibody screening. Code 86806 is the visual crossmatch of serum against donor lymphocytes.
86825HLA crossmatchFirst serum sample or dilution$109.49
86825 is an HLA crossmatch using a non-cytotoxic method; 86806 is a lymphocytotoxicity crossmatch.

86806 billing questions

When is 86806 appropriate instead of 86805?

Use 86806 for the visual lymphocytotoxicity crossmatch performed without titration. Code 86805 identifies a related lymphocytotoxicity assay.

Is 86806 a crossmatch or an antibody screen?

It is a visual crossmatch assessing recipient serum against donor lymphocytes. Cytotoxic antibody screening is a separate service.

What should the documentation describe?

Document the visual lymphocytotoxicity crossmatch and its performance without antibody titration.

Does Medicare pay 86806 under the physician fee schedule?

No. Medicare pays this test through the CLFS; it is excluded from the physician fee schedule by statute.

Does the CLFS payment vary by location or place of service?

No. One national amount applies across states and localities, with no geographic or office-versus-facility adjustment.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 86806PUF_CLFS_CY2026_Q4V1.csv, line 1,829 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 86806?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 86806 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist